38496508|t|Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies.
38496508|a|Whether neurodegenerative diseases linked to misfolding of the same protein share genetic risk drivers or whether different protein-aggregation pathologies in neurodegeneration are mechanistically related remains uncertain. Conventional genetic analyses are underpowered to address these questions. Through careful selection of patients based on protein aggregation phenotype (rather than clinical diagnosis) we can increase statistical power to detect associated variants in a targeted set of genes that modify proteotoxicities. Genetic modifiers of alpha-synuclein (alphaS) and beta-amyloid (Abeta) cytotoxicity in yeast are enriched in risk factors for Parkinson's disease (PD) and Alzheimer's disease (AD), respectively. Here, along with known AD/PD risk genes, we deeply sequenced exomes of 430 alphaS/Abeta modifier genes in patients across alpha-synucleinopathies (PD, Lewy body dementia and multiple system atrophy). Beyond known PD genes GBA1 and LRRK2 , rare variants AD genes ( CD33 , CR1 and PSEN2 ) and Abeta toxicity modifiers involved in RhoA/actin cytoskeleton regulation ( ARGHEF1, ARHGEF28, MICAL3, PASK, PKN2, PSEN2 ) were shared risk factors across synucleinopathies. Actin pathology occurred in iPSC synucleinopathy models and RhoA downregulation exacerbated alphaS pathology. Even in sporadic PD, the expression of these genes was altered across CNS cell types. Genome-wide CRISPR screens revealed the essentiality of PSEN2 in both human cortical and dopaminergic neurons, and PSEN2 mutation carriers exhibited diffuse brainstem and cortical synucleinopathy independent of AD pathology. PSEN2 contributes to a common-risk signal in PD GWAS and regulates alphaS expression in neurons. Our results identify convergent mechanisms across synucleinopathies, some shared with AD.
38496508	19	33	proteotoxicity	Disease	
38496508	60	72	Presenilin-2	Gene	5664
38496508	125	148	alpha-synucleinopathies	Disease	MESH:D000080874
38496508	158	184	neurodegenerative diseases	Disease	MESH:D019636
38496508	309	326	neurodegeneration	Disease	MESH:D019636
38496508	478	486	patients	Species	9606
38496508	701	716	alpha-synuclein	Gene	6622
38496508	718	724	alphaS	Gene	112935892
38496508	744	749	Abeta	Gene	351
38496508	767	772	yeast	Species	4932
38496508	806	825	Parkinson's disease	Disease	MESH:D010300
38496508	827	829	PD	Disease	MESH:D010300
38496508	835	854	Alzheimer's disease	Disease	MESH:D000544
38496508	856	858	AD	Disease	MESH:D000544
38496508	898	900	AD	Disease	MESH:D000544
38496508	901	903	PD	Disease	MESH:D010300
38496508	950	956	alphaS	Gene	112935892
38496508	957	962	Abeta	Gene	351
38496508	981	989	patients	Species	9606
38496508	997	1020	alpha-synucleinopathies	Disease	MESH:D000080874
38496508	1022	1024	PD	Disease	MESH:D010300
38496508	1026	1044	Lewy body dementia	Disease	MESH:D020961
38496508	1049	1072	multiple system atrophy	Disease	MESH:D019578
38496508	1088	1090	PD	Disease	MESH:D010300
38496508	1097	1101	GBA1	Gene	2629
38496508	1106	1111	LRRK2	Gene	120892
38496508	1128	1130	AD	Disease	MESH:D000544
38496508	1154	1159	PSEN2	Gene	5664
38496508	1166	1171	Abeta	Gene	351
38496508	1172	1180	toxicity	Disease	MESH:D064420
38496508	1203	1207	RhoA	Gene	387
38496508	1249	1257	ARHGEF28	Gene	64283
38496508	1259	1265	MICAL3	Gene	57553
38496508	1267	1271	PASK	Gene	23178
38496508	1273	1277	PKN2	Gene	5586
38496508	1279	1284	PSEN2	Gene	5664
38496508	1319	1336	synucleinopathies	Disease	MESH:D000080874
38496508	1371	1386	synucleinopathy	Disease	MESH:D000080874
38496508	1398	1402	RhoA	Gene	387
38496508	1430	1436	alphaS	Gene	112935892
38496508	1465	1467	PD	Disease	MESH:D010300
38496508	1590	1595	PSEN2	Gene	5664
38496508	1604	1609	human	Species	9606
38496508	1649	1654	PSEN2	Gene	5664
38496508	1714	1729	synucleinopathy	Disease	MESH:D000080874
38496508	1745	1747	AD	Disease	MESH:D000544
38496508	1759	1764	PSEN2	Gene	5664
38496508	1804	1806	PD	Disease	MESH:D010300
38496508	1826	1832	alphaS	Gene	112935892
38496508	1906	1923	synucleinopathies	Disease	MESH:D000080874
38496508	1942	1944	AD	Disease	MESH:D000544
38496508	Association	MESH:D010300	120892
38496508	Association	387	5664
38496508	Association	MESH:D064420	57553
38496508	Association	MESH:D064420	5586
38496508	Association	MESH:D010300	112935892
38496508	Association	MESH:D010300	351
38496508	Association	MESH:D000080874	5664
38496508	Association	MESH:D000080874	57553
38496508	Association	MESH:D000080874	5586
38496508	Association	MESH:D064420	387
38496508	Association	MESH:D000544	5664
38496508	Association	23178	387
38496508	Association	MESH:D064420	5664
38496508	Association	MESH:D000080874	387
38496508	Association	MESH:D010300	6622
38496508	Association	MESH:D064420	23178
38496508	Association	MESH:D000544	112935892
38496508	Association	23178	351
38496508	Association	351	5586
38496508	Association	MESH:D064420	351
38496508	Association	MESH:D000080874	120892
38496508	Association	MESH:D000544	6622
38496508	Positive_Correlation	112935892	5664
38496508	Association	387	64283
38496508	Association	MESH:D010300	2629
38496508	Association	MESH:D064420	64283
38496508	Association	MESH:D010300	5664
38496508	Association	351	64283
38496508	Association	MESH:D000544	351
38496508	Association	112935892	387
38496508	Association	MESH:D000080874	23178
38496508	Association	351	387
38496508	Association	351	5664
38496508	Association	MESH:D000080874	64283
38496508	Association	351	57553
38496508	Association	MESH:D000080874	2629

